These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14147259)

  • 21. Harnessing the anti-inflammatory effects of topical dapsone for management of acne.
    Kircik LH
    J Drugs Dermatol; 2010 Jun; 9(6):667-71. PubMed ID: 20645528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Importance of Recognizing Yeast Acne Malessezia versus Propionbacterium.
    Coleman J; Johnson SM
    J Ark Med Soc; 2017 Jan; 113(7):164-165. PubMed ID: 30085463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Special topical approach to the treatment of acne. Suppression of sweating with aluminum chloride in an anhydrous formulation.
    Hurley HJ; Shelley WB
    Cutis; 1978 Dec; 22(6):696-703. PubMed ID: 152694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris.
    Vogt K; Hahn H; Hermann J; Haustein UF; Blume U; Gollnick H; Orfanos CE
    Drugs; 1995; 49 Suppl 2():266-8. PubMed ID: 8549327
    [No Abstract]   [Full Text] [Related]  

  • 25. Trimethoprim-sulphamethoxazole versus placebo in acne vulgaris.
    Macdonald RH; Macconnell LE; Dunsmore IR
    Br J Clin Pract; 1972 Feb; 26(2):97-8. PubMed ID: 4259578
    [No Abstract]   [Full Text] [Related]  

  • 26. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
    Draelos ZD; Carter E; Maloney JM; Elewski B; Poulin Y; Lynde C; Garrett S;
    J Am Acad Dermatol; 2007 Mar; 56(3):439.e1-10. PubMed ID: 17208334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled trial to determine the efficacy and safety of lactoferrin with vitamin E and zinc as an oral therapy for mild to moderate acne vulgaris.
    Chan H; Chan G; Santos J; Dee K; Co JK
    Int J Dermatol; 2017 Jun; 56(6):686-690. PubMed ID: 28369875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging Therapies for Acne Vulgaris.
    Trivedi MK; Bosanac SS; Sivamani RK; Larsen LN
    Am J Clin Dermatol; 2018 Aug; 19(4):505-516. PubMed ID: 29594974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [POLYVIDONE-IODINE IN EXTERNAL APPLICATIONS].
    MEYER-DE-SCHMID JJ
    Gaz Med Fr; 1964 Nov; 71():3814-7. PubMed ID: 14228430
    [No Abstract]   [Full Text] [Related]  

  • 30. What is the role of antimicrobial peptides (AMP) in acne vulgaris?
    Harder J; Tsuruta D; Murakami M; Kurokawa I
    Exp Dermatol; 2013 Jun; 22(6):386-91. PubMed ID: 23711061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human beta defensins: a new perspective in acne treatment?].
    Körber A; Lehnen M; Grabbe S; Dissemond J
    Dtsch Med Wochenschr; 2005 Feb; 130(5):210-2. PubMed ID: 15678389
    [No Abstract]   [Full Text] [Related]  

  • 32. Direct analysis of resistance in the cutaneous microflora during treatment of acne vulgaris with topical 1% nadifloxacin and 2% erythromycin.
    Bojar RA; Hittel N; Cunliffe WJ; Holland KT
    Drugs; 1995; 49 Suppl 2():164-7. PubMed ID: 8549289
    [No Abstract]   [Full Text] [Related]  

  • 33. A technic for testing acegenic potency in rabbits, applied to the potent acnegen, 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    JONES EL; KRIZEK H
    J Invest Dermatol; 1962 Dec; 39():511-7. PubMed ID: 13964713
    [No Abstract]   [Full Text] [Related]  

  • 34. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.
    Stotland M; Shalita AR; Kissling RF
    Am J Clin Dermatol; 2009; 10(4):221-7. PubMed ID: 19489655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable.
    Tanghetti E; Harper JC; Oefelein MG
    J Drugs Dermatol; 2012 Dec; 11(12):1417-21. PubMed ID: 23377510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.
    Stein Gold LF; Jarratt MT; Bucko AD; Grekin SK; Berlin JM; Bukhalo M; Weiss JS; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A
    J Drugs Dermatol; 2016 May; 15(5):553-61. PubMed ID: 27168264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris.
    Thiboutot DM; Willmer J; Sharata H; Halder R; Garrett S
    Clin Pharmacokinet; 2007; 46(8):697-712. PubMed ID: 17655376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acne therapy.
    HORNE SF
    Med Times; 1961 Jul; 89():730-1. PubMed ID: 13715891
    [No Abstract]   [Full Text] [Related]  

  • 39. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of seborrhea, seborrheic eczema and acne with a soap with a mesulfen base].
    Leoni A; Dudine G
    G Ital Dermatol Venereol; 1983; 118(2):XXI-XXIV. PubMed ID: 6226594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.